AAP IMPLANTATE (AAQ1.DE) Fundamental Analysis & Valuation
FRA:AAQ1 • DE000A3H2101
Current stock price
2.06 EUR
-0.08 (-3.74%)
Last:
This AAQ1.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. AAQ1.DE Profitability Analysis
1.1 Basic Checks
- AAQ1 had negative earnings in the past year.
- In the past year AAQ1 has reported a negative cash flow from operations.
- In the past 5 years AAQ1 always reported negative net income.
- AAQ1 had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of AAQ1 (-25.96%) is worse than 79.31% of its industry peers.
- AAQ1 has a worse Return On Equity (-38.70%) than 72.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -25.96% | ||
| ROE | -38.7% | ||
| ROIC | N/A |
ROA(3y)-27.22%
ROA(5y)-27.6%
ROE(3y)-50.99%
ROE(5y)-51.91%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Gross Margin, with a value of 87.45%, AAQ1 belongs to the top of the industry, outperforming 96.55% of the companies in the same industry.
- In the last couple of years the Gross Margin of AAQ1 has remained more or less at the same level.
- AAQ1 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.45% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.81%
GM growth 5Y-0.65%
2. AAQ1.DE Health Analysis
2.1 Basic Checks
- AAQ1 does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for AAQ1 has been increased compared to 1 year ago.
- Compared to 5 years ago, AAQ1 has more shares outstanding
- The debt/assets ratio for AAQ1 has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 1.40, we must say that AAQ1 is in the distress zone and has some risk of bankruptcy.
- AAQ1 has a worse Altman-Z score (1.40) than 68.97% of its industry peers.
- A Debt/Equity ratio of 0.03 indicates that AAQ1 is not too dependend on debt financing.
- AAQ1 has a Debt to Equity ratio of 0.03. This is amongst the best in the industry. AAQ1 outperforms 91.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.4 |
ROIC/WACCN/A
WACC7.25%
2.3 Liquidity
- AAQ1 has a Current Ratio of 2.40. This indicates that AAQ1 is financially healthy and has no problem in meeting its short term obligations.
- AAQ1 has a better Current ratio (2.40) than 67.24% of its industry peers.
- A Quick Ratio of 1.24 indicates that AAQ1 should not have too much problems paying its short term obligations.
- AAQ1 has a Quick ratio of 1.24. This is comparable to the rest of the industry: AAQ1 outperforms 48.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.4 | ||
| Quick Ratio | 1.24 |
3. AAQ1.DE Growth Analysis
3.1 Past
- AAQ1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.21%, which is quite impressive.
- The Revenue has been growing slightly by 6.32% in the past year.
- The Revenue has been growing slightly by 0.78% on average over the past years.
EPS 1Y (TTM)63.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.53%
Revenue 1Y (TTM)6.32%
Revenue growth 3Y0.1%
Revenue growth 5Y0.78%
Sales Q2Q%-3.32%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- AAQ1 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.66% yearly.
EPS Next Y65%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15.38%
Revenue Next 2Y22.14%
Revenue Next 3Y12.95%
Revenue Next 5Y11.66%
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. AAQ1.DE Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for AAQ1. In the last year negative earnings were reported.
- Also next year AAQ1 is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. AAQ1.DE Dividend Analysis
5.1 Amount
- No dividends for AAQ1!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AAQ1.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:AAQ1 (4/28/2026, 10:26:24 AM)
2.06
-0.08 (-3.74%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)04-30 2026-04-30
Inst Owners23.06%
Inst Owner ChangeN/A
Ins Owners15.97%
Ins Owner ChangeN/A
Market Cap30.32M
Revenue(TTM)12.20M
Net Income(TTM)-3.63M
Analysts42.22
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.48 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.23 | ||
| P/tB | 4.03 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.35
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.83
BVpS0.64
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -25.96% | ||
| ROE | -38.7% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.45% | ||
| FCFM | N/A |
ROA(3y)-27.22%
ROA(5y)-27.6%
ROE(3y)-50.99%
ROE(5y)-51.91%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.81%
GM growth 5Y-0.65%
F-Score6
Asset Turnover0.87
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 32.08% | ||
| Cap/Sales | 4.82% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.4 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 1.4 |
F-Score6
WACC7.25%
ROIC/WACCN/A
Cap/Depr(3y)18.89%
Cap/Depr(5y)19.66%
Cap/Sales(3y)3.48%
Cap/Sales(5y)3.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.53%
EPS Next Y65%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.32%
Revenue growth 3Y0.1%
Revenue growth 5Y0.78%
Sales Q2Q%-3.32%
Revenue Next Year15.38%
Revenue Next 2Y22.14%
Revenue Next 3Y12.95%
Revenue Next 5Y11.66%
EBIT growth 1Y61.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year173.33%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y63.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y86.19%
OCF growth 3YN/A
OCF growth 5YN/A
AAP IMPLANTATE / AAQ1.DE Fundamental Analysis FAQ
What is the fundamental rating for AAQ1 stock?
ChartMill assigns a fundamental rating of 2 / 10 to AAQ1.DE.
What is the valuation status of AAP IMPLANTATE (AAQ1.DE) stock?
ChartMill assigns a valuation rating of 0 / 10 to AAP IMPLANTATE (AAQ1.DE). This can be considered as Overvalued.
How profitable is AAP IMPLANTATE (AAQ1.DE) stock?
AAP IMPLANTATE (AAQ1.DE) has a profitability rating of 1 / 10.